Cortney Caudill serves as Executive at HALOZYME THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Cortney Caudill has executed 5 insider transactions totaling $277.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 20, 2026 involved exercising options for 2,666 shares valued at $0.
Cortney Caudill currently holds 7,998 shares of HALOZYME THERAPEUTICS, INC. (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cortney Caudill has been a net seller of HALO stock. They have purchased $0 and sold $277.9K worth of shares.
Cortney Caudill's most recent insider trade was on Feb 20, 2026, when they sold 2,666 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $70.98 |
| Discretionary |
| Feb 20, 2026 | HALO | $0 | Option Exercise | 2,666 | $N/A | Discretionary |
| Nov 1, 2025 | HALO | $277.9K | Sale | 4,263 | $65.19 | Discretionary |
| Nov 1, 2025 | HALO | $0 | Option Exercise | 9,326 | $N/A | Discretionary |